Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Upadacitinib is effective and safe for long-term treatment of alopecia areata, especially for those with an atopic background.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

Upadacitinib effectively treats severe alopecia areata and is safe.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

Baricitinib helps regrow hair in severe alopecia areata.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

An elderly Chinese man lost all his hair after taking a new heart medication.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

JAK inhibitors may help improve symptoms in adults with APECED.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Oclacitinib maleate successfully treated alopecia in Andean bears.

NXC736 significantly reduced hair loss in mice with alopecia areata.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

The patch effectively promotes hair growth for alopecia areata without pain.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib effectively treated both alopecia areata and Crohn's disease in a 12-year-old.